Clinical Trial Update: Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP [EARLY_Phase 1]

View source ↗

Summary

Early-phase study evaluating two intrathecal dexmedetomidine doses as an adjuvant in elderly patients undergoing Holmium Laser Enucleation of the Prostate (HoLE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mansoura University | Conditions: Transurethral Resection of Prostate | EARLY_Phase 1 | Status: COMPLETED